Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
BeiGene, bendamustine, cardiac, Coleman, College, concomitant, Distinguished, Dr, GPO, headcount, hepatic, Lawrence, Morton, renal, shareholder, Stanford, Steinman, University, zanubrutinib, Zimmermann
Removed:
alkylating, BTD, fight, IRC, orally, potent, selective
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view